Canada markets open in 8 hours 35 minutes
  • S&P/TSX

    20,595.89
    +4.89 (+0.02%)
     
  • S&P 500

    4,349.93
    -6.52 (-0.15%)
     
  • DOW

    34,168.09
    -129.61 (-0.38%)
     
  • CAD/USD

    0.7865
    -0.0030 (-0.39%)
     
  • CRUDE OIL

    86.58
    -0.77 (-0.88%)
     
  • BTC-CAD

    45,796.82
    -2,525.88 (-5.23%)
     
  • CMC Crypto 200

    820.12
    -35.70 (-4.17%)
     
  • GOLD FUTURES

    1,812.00
    -17.70 (-0.97%)
     
  • RUSSELL 2000

    1,976.46
    -27.57 (-1.38%)
     
  • 10-Yr Bond

    1.8480
    0.0000 (0.00%)
     
  • NASDAQ futures

    13,947.00
    -211.50 (-1.49%)
     
  • VOLATILITY

    31.96
    +0.80 (+2.57%)
     
  • FTSE

    7,469.78
    +98.32 (+1.33%)
     
  • NIKKEI 225

    26,212.47
    -798.86 (-2.96%)
     
  • CAD/EUR

    0.7011
    -0.0009 (-0.13%)
     

Bahrain approves Pfizer/BioNTech COVID-19 vaccine

DUBAI (Reuters) - Bahrain said on Friday it has granted emergency use authorisation for the Pfizer/BioNTech COVID-19 vaccine, becoming the second country after Britain to approve it.

The Gulf Arab state had also approved Sinopharm's COVID-19 vaccine in November for use by frontline workers.

"The approval of the Pfizer/BioNTech vaccine will add a further important layer to the Kingdom's national COVID-19 response," Dr. Mariam Al Jalahma, CEO of Bahrain's National Health Regulatory Authority said in a statement.

(Reporting by Ghaida Ghantous, editing by Louise Heavens)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting